Biological Studies and Target Engagement of the 2- C-Methyl-d-Erythritol 4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent (1 R,3 S)-MMV008138 and Analogs.
暂无分享,去创建一个
M. Cassera | E. F. Merino | J. H. Butler | M. Totrov | P. Carlier | M. L. Fernández-Murga | D. J. Slade | Priscilla M Krai | Rubayet Elahi | M. Ghavami | Zhong-Ke Yao | M. Simpson | Michael A. Casasanta | E. Merino | J. Butler
[1] N. Strynadka,et al. Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B* , 2016, The Journal of Biological Chemistry.
[2] N. Strynadka,et al. Escherichia coli Penicillin-Binding Protein 1B: Structural Insights into Inhibition. , 2016 .
[3] Manuel Llinás,et al. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond , 2016, PLoS pathogens.
[4] D. Vertommen,et al. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan , 2016, Nature Communications.
[5] Jeremy L. Praissman,et al. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition , 2016, eLife.
[6] T. Brummelkamp,et al. Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation. , 2015, Chemistry & biology.
[7] Christopher M. Armstrong,et al. Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target. , 2015, ACS infectious diseases.
[8] M. Cassera,et al. Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure-activity studies. , 2015, Bioorganic & medicinal chemistry letters.
[9] M. Cassera,et al. Isoprenoid Precursor Biosynthesis Is the Essential Metabolic Role of the Apicoplast during Gametocytogenesis in Plasmodium falciparum , 2014, Eukaryotic Cell.
[10] J. Derisi,et al. A Chemical Rescue Screen Identifies a Plasmodium falciparum Apicoplast Inhibitor Targeting MEP Isoprenoid Precursor Biosynthesis , 2014, Antimicrobial Agents and Chemotherapy.
[11] M. Cassera,et al. Comprehensive quantitative analysis of purines and pyrimidines in the human malaria parasite using ion-pairing ultra-performance liquid chromatography-mass spectrometry. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] Y. Li,et al. Biomarkers identified by urinary metabonomics for noninvasive diagnosis of nutritional rickets. , 2014, Journal of proteome research.
[13] F. Diederich,et al. Pseudilins: halogenated, allosteric inhibitors of the non-mevalonate pathway enzyme IspD. , 2014, Angewandte Chemie.
[14] M. Cassera,et al. Antiapicoplast and Gametocytocidal Screening To Identify the Mechanisms of Action of Compounds within the Malaria Box , 2013, Antimicrobial Agents and Chemotherapy.
[15] J. Bessoule,et al. Host-Pathogen Interaction and Signaling Molecule Secretion Are Modified in the dpp3 Knockout Mutant of Candida lusitaniae , 2013, Infection and Immunity.
[16] G. V. van Dooren,et al. The algal past and parasite present of the apicoplast. , 2013, Annual review of microbiology.
[17] Jeremy N. Burrows,et al. The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases , 2013, PloS one.
[18] Jordi Perez-Gil,et al. Metabolic plasticity for isoprenoid biosynthesis in bacteria. , 2013, The Biochemical journal.
[19] M. Scholfield,et al. Halogen bonding (X‐bonding): A biological perspective , 2013, Protein science : a publication of the Protein Society.
[20] G. McFadden,et al. Targeting apicoplasts in malaria parasites , 2013, Expert opinion on therapeutic targets.
[21] Christian Gilissen,et al. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan , 2012, Nature Genetics.
[22] Francesco Muntoni,et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome , 2012, Nature Genetics.
[23] Francisco-Javier Gamo,et al. Global phenotypic screening for antimalarials. , 2012, Chemistry & biology.
[24] Joseph L. DeRisi,et al. Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparum , 2011, PLoS biology.
[25] G. McFadden,et al. Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii , 2011, The Journal of experimental medicine.
[26] P. Roepe,et al. Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine. , 2011, Molecular and biochemical parasitology.
[27] K. M. Watts,et al. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling. , 2011, Biochemistry.
[28] A. Magill,et al. Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis , 2011, The American journal of tropical medicine and hygiene.
[29] W. V. Van Voorhis,et al. Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene. , 2010, Molecular and biochemical parasitology.
[30] P. Rosenthal,et al. Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. , 2008, Trends in parasitology.
[31] M. Cassera,et al. Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum. , 2007, Memorias do Instituto Oswaldo Cruz.
[32] Joseph L. DeRisi,et al. Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparum , 2006, Antimicrobial Agents and Chemotherapy.
[33] M. Pop,et al. Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.
[34] M. Cassera,et al. The Methylerythritol Phosphate Pathway Is Functionally Active in All Intraerythrocytic Stages of Plasmodium falciparum* , 2004, Journal of Biological Chemistry.
[35] Y. Horiguchi,et al. A Synthesis of Chiral 1,1,3-Trisubstituted 1,2,3,4-Tetrahydro-β-carbolines by the Pictet—Spengler Reaction of Tryptophan and Ketones: Conversion of (1R,3S)-Diastereomers into Their (1S,3S)-Counterparts by Scission of the C(1)—N(2) Bond. , 2004 .
[36] P. Wilairat,et al. Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening , 2004, Antimicrobial Agents and Chemotherapy.
[37] Y. Horiguchi,et al. A synthesis of chiral 1,1,3-trisubstituted 1,2,3,4-tetrahydro-beta-carbolines by the Pictet-Spengler reaction of tryptophan and ketones: conversion of (1R,3S)-diastereomers into their (1S,3S)-counterparts by scission of the C(1)-N(2) bond. , 2003, Chemical & pharmaceutical bulletin.
[38] H. Lichtenthaler,et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. , 1999, Science.
[39] Robert W. Weber,et al. General method for the assignment of stereochemistry of 1,3-disubstituted 1,2,3,4-tetrahydro-.beta.-carbolines by carbon-13 spectroscopy , 1980 .
[40] C. Dolea,et al. World Health Organization , 1949, International Organization.